
Chong Kun Dang Pharmaceutical Corp
KRX:185750

Intrinsic Value
The intrinsic value of one
Chong Kun Dang Pharmaceutical Corp
stock under the Base Case scenario is
80 809.93
KRW.
Compared to the current market price of 78 000 KRW,
Chong Kun Dang Pharmaceutical Corp
is
Undervalued by 3%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Chong Kun Dang Pharmaceutical Corp
Fundamental Analysis



Revenue & Expenses Breakdown
Chong Kun Dang Pharmaceutical Corp
Balance Sheet Decomposition
Chong Kun Dang Pharmaceutical Corp
Current Assets | 962.2B |
Cash & Short-Term Investments | 301.6B |
Receivables | 298.5B |
Other Current Assets | 362.1B |
Non-Current Assets | 496.6B |
Long-Term Investments | 67.9B |
PP&E | 320.8B |
Intangibles | 75.6B |
Other Non-Current Assets | 32.3B |
Free Cash Flow Analysis
Chong Kun Dang Pharmaceutical Corp
KRW | |
Free Cash Flow | KRW |
Earnings Waterfall
Chong Kun Dang Pharmaceutical Corp
Revenue
|
1.6T
KRW
|
Cost of Revenue
|
-1.1T
KRW
|
Gross Profit
|
532.6B
KRW
|
Operating Expenses
|
-433.1B
KRW
|
Operating Income
|
99.5B
KRW
|
Other Expenses
|
9.6B
KRW
|
Net Income
|
109.1B
KRW
|
Profitability Score
Profitability Due Diligence
Chong Kun Dang Pharmaceutical Corp's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

Score
Chong Kun Dang Pharmaceutical Corp's profitability score is 56/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Chong Kun Dang Pharmaceutical Corp's solvency score is 72/100. The higher the solvency score, the more solvent the company is.

Score
Chong Kun Dang Pharmaceutical Corp's solvency score is 72/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Chong Kun Dang Pharmaceutical Corp
According to Wall Street analysts, the average 1-year price target for
Chong Kun Dang Pharmaceutical Corp
is 123 998.44 KRW
with a low forecast of 96 190.49 KRW and a high forecast of 149 100 KRW.
Dividends
Current shareholder yield for Chong Kun Dang Pharmaceutical Corp is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
Chong Kun Dang Pharmaceutical Corp
stock under the Base Case scenario is
80 809.93
KRW.
Compared to the current market price of 78 000 KRW,
Chong Kun Dang Pharmaceutical Corp
is
Undervalued by 3%.